Search Results - "Pryce, G."

Refine Results
  1. 1

    COVID‐19 vaccine‐readiness for anti‐CD20‐depleting therapy in autoimmune diseases by Baker, D., Roberts, C. A. K., Pryce, G., Kang, A. S., Marta, M., Reyes, S., Schmierer, K., Giovannoni, G., Amor, S.

    Published in Clinical and experimental immunology (01-11-2020)
    “…Based on the known and emerging biology of autoimmune diseases and COVID‐19, it was hypothesised that whilst B‐cell depletion should not necessarily expose…”
    Get full text
    Journal Article
  2. 2

    Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain by Cristino, L., de Petrocellis, L., Pryce, G., Baker, D., Guglielmotti, V., Di Marzo, V.

    Published in Neuroscience (2006)
    “…Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels have been proposed to act as metabotropic and ionotropic receptors,…”
    Get full text
    Journal Article
  3. 3

    Control of Spasticity in a Multiple Sclerosis Model is mediated by CB 1 , not CB 2 , Cannabinoid Receptors by Pryce, G, Baker, D

    Published in British journal of pharmacology (29-01-2009)
    “…Background and Purpose: There is increasing evidence to suggest that cannabis can ameliorate muscle‐spasticity in multiple sclerosis, as was objectively shown…”
    Get full text
    Journal Article
  4. 4

    Failed B cell survival factor trials support the importance of memory B cells in multiple sclerosis by Baker, D., Pryce, G., James, L. K., Schmierer, K., Giovannoni, G.

    Published in European journal of neurology (01-02-2020)
    “…Clinical trials are probably the most informative experiments to help an understanding of multiple sclerosis (MS) biology. Recent successes with CD20‐depleting…”
    Get full text
    Journal Article
  5. 5

    Cannabinoid control of neuroinflammation related to multiple sclerosis by Baker, D, Jackson, S J, Pryce, G

    Published in British journal of pharmacology (01-11-2007)
    “…The cannabis plant (Cannabis sativa) has been known by many names but the question remains ‘Can we call it medicine?’ There has been renewed interest in the…”
    Get full text
    Journal Article
  6. 6

    Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis by Anderson, J. M., Hampton, D. W., Patani, R., Pryce, G., Crowther, R. A., Reynolds, R., Franklin, R. J. M., Giovannoni, G., Compston, D. A. S., Baker, D., Spillantini, M. G., Chandran, S.

    Published in Brain (London, England : 1878) (01-07-2008)
    “…The pathological correlate of clinical disability and progression in multiple sclerosis is neuronal and axonal loss; however, the underlying mechanisms are…”
    Get full text
    Journal Article
  7. 7

    Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors by Pryce, G, Cabranes, A, Fernández-Ruiz, J, Bisogno, T, Di Marzo, V, Long, JZ, Cravatt, BF, Giovannoni, G, Baker, D

    Published in Multiple sclerosis (01-12-2013)
    “…Background: It has been previously shown that CB1 cannabinoid receptor agonism using cannabis extracts alleviates spasticity in both a mouse experimental…”
    Get full text
    Journal Article
  8. 8

    Mitigation of Reactive Human Cell Adhesion on Poly(dimethylsiloxane) by Immobilized Trypsin by Achyuta, Anil Kumar H, Stephens, Kyle D, Pryce Lewis, Hilton G, Murthy, Shashi K

    Published in Langmuir (16-03-2010)
    “…Occlusion or blockage of silicone shunts utilized in the treatment of hydrocephalus is a major challenge that is currently addressed by multiple shunt…”
    Get full text
    Journal Article
  9. 9

    Cannabinoids inhibit neurodegeneration in models of multiple sclerosis by Pryce, Gareth, Ahmed, Zubair, Hankey, Deborah J. R., Jackson, Samuel J., Croxford, J. Ludovic, Pocock, Jennifer M., Ledent, Catherine, Petzold, Axel, Thompson, Alan J., Giovannoni, Gavin, Cuzner, M. Louise, Baker, David

    Published in Brain (London, England : 1878) (01-10-2003)
    “…Multiple sclerosis is increasingly being recognized as a neurodegenerative disease that is triggered by inflammatory attack of the CNS. As yet there is no…”
    Get full text
    Journal Article
  10. 10

    Endocannabinoids control spasticity in a multiple sclerosis model by Baker, David, Pryce, Gareth, Croxford, J. Ludovic, Brown, Peter, Pertwee, Roger G., Makriyannis, Alexandros, Khanolkar, Atmaram, Layward, Lorna, Fezza, Filomena, Bisogno, Tiziana, Marzo, Vincenzo Di

    Published in The FASEB journal (01-02-2001)
    “…ABSTRACT Spasticity is a complicating sign in multiple sclerosis that also develops in a model of chronic relapsing experimental autoimmune encephalomyelitis…”
    Get full text
    Journal Article
  11. 11

    Incorporation of Linear Spacer Molecules in Vapor-Deposited Silicone Polymer Thin Films by Achyuta, Anil Kumar H, White, Aleksandr J, Pryce Lewis, Hilton G, Murthy, Shashi K

    Published in Macromolecules (24-03-2009)
    “…Poly(trivinyltrimethylcyclotrisiloxane) or polyV3D3 is a promising insulating thin film known for its potential application in neural probe fabrication…”
    Get full text
    Journal Article
  12. 12

    Biocompatibility Assessment of Insulating Silicone Polymer Coatings Using an in vitro Glial Scar Assay by Achyuta, Anil Kumar H., Polikov, Vadim S., White, Aleksandr J., Lewis, Hilton G. Pryce, Murthy, Shashi K.

    Published in Macromolecular bioscience (11-08-2010)
    “…Vapor‐deposited silicone coatings are attractive candidates for providing insulation in neuroprosthetic devices owing to their excellent resistivity, adhesion,…”
    Get full text
    Journal Article
  13. 13

    HWCVD of polymers: Commercialization and scale-up by Pryce Lewis, Hilton G., Bansal, Neeta P., White, Aleksandr J., Handy, Erik S.

    Published in Thin solid films (30-04-2009)
    “…GVD Corporation specializes in process development and equipment design for the production of ultra-thin polymer coatings using hot wire chemical vapor…”
    Get full text
    Journal Article Conference Proceeding
  14. 14

    Evaluating potential therapies for bladder dysfunction in a mouse model of multiple sclerosis with high-resolution ultrasonography by Al-Izki, S, Pryce, G, Giovannoni, G, Baker, D

    Published in Multiple sclerosis (01-07-2009)
    “…Background In multiple sclerosis (MS), demyelinating and neurodegenerative lesions develop throughout the central nervous system, which result in a loss of…”
    Get full text
    Journal Article
  15. 15

    Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation by Jackson, S.J., Pryce, G., Diemel, L.T., Cuzner, M.L., Baker, D.

    Published in Neuroscience (2005)
    “…Administered cannabinoids have been shown to ameliorate signs of CNS inflammatory disease in a number of animal models, including allergic encephalomyelitis…”
    Get full text
    Journal Article
  16. 16

    Chronic relapsing experimental allergic encephalomyelitis (CREAE) in plasminogen activator inhibitor-1 knockout mice: the effect of fibrinolysis during neuroinflammation by East, E., Gverić, D., Baker, D., Pryce, G., Lijnen, H. R., Cuzner, M. L.

    Published in Neuropathology and applied neurobiology (01-04-2008)
    “…During neuroinflammation in multiple sclerosis (MS) fibrinogen, not normally present in the brain or spinal cord, enters the central nervous system through a…”
    Get full text
    Journal Article
  17. 17

    Polymeric nanocoatings by hot-wire chemical vapor deposition (HWCVD) by Lau, Kenneth K.S., Mao, Yu, Pryce Lewis, Hilton G., Murthy, Shashi K., Olsen, Brad D., Loo, Leslie S., Gleason, Karen K.

    Published in Thin solid films (20-04-2006)
    “…Hot-wire chemical vapor deposition (HWCVD) of polymers affords the ability to coat objects of complex shape and nanoscale features. Using hot filaments to…”
    Get full text
    Journal Article Conference Proceeding
  18. 18

    Pulsed-PECVD Films from Hexamethylcyclotrisiloxane for Use as Insulating Biomaterials by Pryce Lewis, Hilton G, Edell, David J, Gleason, Karen K

    Published in Chemistry of materials (01-11-2000)
    “…Thin films produced by plasma-enhanced chemical vapor deposition (PECVD) have potential application as conformal coatings on implantable devices with complex…”
    Get full text
    Journal Article
  19. 19

    Avoidance Coping and HIV Risk Behavior among Gay Men by Martin, James I., Pryce, Jo G., Leeper, James D.

    Published in Health & social work (01-08-2005)
    “…This study describes how coping strategies are related to unprotected anal intercourse (UAI) among gay men, and provides support for a new theoretical…”
    Get full text
    Journal Article
  20. 20

    Quantification of neurodegeneration by measurement of brain-specific proteins by Petzold, A., Baker, D., Pryce, G., Keir, G., Thompson, E.J., Giovannoni, G.

    Published in Journal of neuroimmunology (01-05-2003)
    “…Quantification of neurodegeneration in animal models is typically assessed by time-consuming and observer-dependent immunocytochemistry. This study aimed to…”
    Get full text
    Journal Article